Skip to content

Tonzonium

Drug profile

Also known as: thonzide, thonzonium, thonzonium bromide, tonzonium bromide

OfpFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tonzonium is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 1962. DrugCentral lists 2 molecular targets, including Dyrk1a and IDE. Recorded indications include Mastoidectomy Cavity Infections and Otitis externa.

  • Approval status: ofp (first approved 1962 by the FDA).
  • Molecular targets: Dyrk1a and IDE (2 listed in DrugCentral).
  • Indications: Mastoidectomy Cavity Infections and Otitis externa.
  • Molecular formula: C32H55N4O; molecular weight 511.82 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Mastoidectomy Cavity Infections
  • Otitis externa

Off-label uses (1)

  • Chronic purulent otitis media

Contraindications (7)

  • Bullous myringitis
  • Fungal ear infection
  • Herpes simplex
  • Herpes zoster auricularis
  • Perforation of tympanic membrane
  • Tuberculosis of ear
  • Viral ear infection

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Dual specificity tyrosine-phosphorylation-regulated kinase 1ADyrk1aunknownAC50 5.03
Insulin-degrading enzymeIDEunknownEC50 4.27

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1962-05-17FDA—PAR STERILE PRODUCTS

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Tonzonium is on its molecule page.

Molecular formulaC32H55N4O
Molecular weight511.82 g/mol
CAS number553-08-2
InChIKeyIOYZYMQFUSNATM-UHFFFAOYSA-N
PubChem CID5456
CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1=CC=C(OC)C=C1)C1=NC=CC=N1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tonzonium used for?

DrugCentral lists the following indications for Tonzonium: Mastoidectomy Cavity Infections and Otitis externa.

How does Tonzonium work?

Its molecular targets in DrugCentral include Dyrk1a and IDE.

When was Tonzonium first approved?

Tonzonium was first approved by the FDA in 1962.

What is the chemical formula of Tonzonium?

Tonzonium has the molecular formula C32H55N4O and a molecular weight of 511.82 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1962-05-17
AgencyFDA
Targets2
Indications2
FormulaC32H55N4O
DrugCentral ID4605
Interactive profile